Nonclinical Biostatistics Working Group

A Message from the Nonclinical Biostatistics Working Group Steering Committee

Thank you for visiting our website! The Nonclinical Biostatistics Working Group (NCBWG) is part of ASA’s Biopharmaceutical Section. We are a collaborative community of statistics professionals across the pharmaceutical industry. The objectives of the NCBWG are as follows:

• Promote the theory and applications of nonclinical biostatistical disciplines through scholarly activities, including publication of journals in statistics and probability, scientific meetings, and other educational programs
• Broaden applications of nonclinical biostatistical techniques in all areas of society, including industry and government
• Promote better understanding and interest by the general public in nonclinical biostatistical methodology and related applications
• Promote better communication through the development of standards and common terminology
• Foster cooperative efforts among educational, research, industrial, and governmental personnel in non-clinical statistical activities

To learn more about the history of the NCBWG, click here. For questions, please contact the NCBWG Chair. Please explore the resources on our webpage, and we look forward to seeing you at future events!

NCBWG Steering Committee

Mariusz Lubomirski,
Amgen
NCBWG Chair
Contact Mariusz

Steven Novick,
Takeda
ASA BIOP
Section Chair

Paul Faya, 
Eli Lilly

Katherine Giacoletti,
Merck

Xin Huang, 
Abbvie

Eve Pickering,
Pfizer

Katja Remlinker,
GSK

Paul Faya, Eli Lilly
Katie Brickey, Pfizer

Jyh-Ming Shoung, Janssen

Wei Zhao, Fate Therapeutics